Cargando…

Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series

BACKGROUND: Chorea in Huntington's Disease (HD) is usually treated with antidopaminergic neuroleptics like haloperidol, olanzapine and tiaprid or dopamine depleting drugs like tetrabenazine. Some patients with hyperkinesia, however, react to treatment with antidopaminergic drugs by developing e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saft, Carsten, Lauter, Thorsten, Kraus, Peter H, Przuntek, Horst, Andrich, Juergen E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413552/ https://www.ncbi.nlm.nih.gov/pubmed/16507108 http://dx.doi.org/10.1186/1471-2377-6-11

Ejemplares similares

Error Processing in Huntington's Disease
por: Beste, Christian, et al.
Publicado: (2006)

Oral and dental health in Huntington‘s disease - an observational study
por: Saft, Carsten, et al.
Publicado: (2013)

Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD)
por: Arning, Larissa, et al.
Publicado: (2005)

PGC-1alpha as modifier of onset age in Huntington disease
por: Taherzadeh-Fard, Elahe, et al.
Publicado: (2009)

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease
por: Mai, Maren, et al.
Publicado: (2006)

Time Processing in Huntington's Disease: A Group-Control Study
por: Beste, Christian, et al.
Publicado: (2007)

Different orthostatic hyperkinesias go “Thump”
por: McKay, Jake H., et al.
Publicado: (2017)

No evidence of impaired gastric emptying in early Huntington‘s Disease
por: Saft, Carsten, et al.
Publicado: (2011)

Glutathione S-Transferase Ω 1 variation does not influence age at onset of Huntington's disease
por: Arning, Larissa, et al.
Publicado: (2004)

Hyperkinesias and Echolalia in Primary Familial Brain Calcification
por: Paucar, Martin, et al.
Publicado: (2020)

Failure to confirm influence of Methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease
por: Hansen, Wiebke, et al.
Publicado: (2005)

Optogenetic Stimulation of GABAergic Neurons in the Globus Pallidus Produces Hyperkinesia
por: Tian, Jun, et al.
Publicado: (2018)

Resurrection of sildenafil: potential for Huntington’s Disease, too?
por: Achenbach, Jannis, et al.
Publicado: (2022)

Development of Hyperkinesias after Long-term Pallidal Stimulation for Idiopathic Segmental Dystonia
por: Wloch, Andreas, et al.
Publicado: (2017)

The Role of the Immune System in Huntington's Disease
por: Ellrichmann, Gisa, et al.
Publicado: (2013)

Music perception and movement deterioration in Huntington’s disease
por: Beste, Christian, et al.
Publicado: (2011)

Biliary hyperkinesia, a new diagnosis or misunderstood pathophysiology of dyskinesia: A case report
por: Bates, John A., et al.
Publicado: (2019)

Differential Diagnosis of Chorea—HIV Infection Delays Diagnosis of Huntington’s Disease by Years
por: Achenbach, Jannis, et al.
Publicado: (2021)

Supracubital perineurioma misdiagnosed as carpal tunnel syndrome: case report
por: Saft, Carsten, et al.
Publicado: (2004)

SOX5-Null Heterozygous Mutation in a Family with Adult-Onset Hyperkinesia and Behavioral Abnormalities
por: Zech, Michael, et al.
Publicado: (2017)

Encephalopathy and Complex Hyperkinesia in a Patient with Severe Acute Respiratory Syndrome Coronavirus-2 Infection
por: Li, Wenyang, et al.
Publicado: (2021)

Biliary Hyperkinesia and Its Association With Bariatric Surgery: A Case Report and Review of Management Strategies
por: Holder, Shaniah S, et al.
Publicado: (2023)

Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease
por: Rusz, Jan, et al.
Publicado: (2014)

Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
por: Auvin, Stéphane
Publicado: (2007)

Another Perspective on Huntington’s Disease: Disease Burden in Family Members and Pre-Manifest HD When Compared to Genotype-Negative Participants from ENROLL-HD
por: Achenbach, Jannis, et al.
Publicado: (2021)

Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington’s Disease—Data from a Real World Cohort
por: Achenbach, Jannis, et al.
Publicado: (2021)

Screening of mutations in NOL3 in a myoclonic syndromes series
por: Macerollo, A., et al.
Publicado: (2014)

Myoclonic Disorders
por: Eberhardt, Olaf, et al.
Publicado: (2017)

Differential improvement of the sleep quality among patients with juvenile myoclonic epilepsy with valproic acid: A longitudinal sleep questionnaire-based study
por: Nayak, Chetan, et al.
Publicado: (2015)

Positive effect of immunomodulatory therapies on disease progression in Huntington’s disease? Data from a real-world cohort
por: Achenbach, Jannis, et al.
Publicado: (2022)

A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data
por: Beste, Christian, et al.
Publicado: (2013)

Schistosoma mansoni excretory-secretory products induce protein kinase signalling, hyperkinesia, and stem cell proliferation in the opposite sex
por: Shakir, Eman M. N., et al.
Publicado: (2023)

Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
por: Makke, Yamane, et al.
Publicado: (2015)

Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington’s Disease
por: Achenbach, Jannis, et al.
Publicado: (2022)

Altered third‐party punishment in Huntington's disease: A study using neuroeconomic games
por: Brüne, Martin, et al.
Publicado: (2020)

Functional and cognitive capacity differ in dystonic motor subtypes when compared to choreatic and hypokinetic‐rigid motor subtypes in Huntington's disease
por: Achenbach, Jannis, et al.
Publicado: (2020)

Severe Hyponatremia Due to Valproic Acid Toxicity
por: Gupta, Ena, et al.
Publicado: (2015)

Time will tell: Decision making in premanifest and manifest Huntington’s disease
por: Heim, Beatrice, et al.
Publicado: (2020)

Progressive Myoclonic Epilepsy Due to Lafora Body Disease with a Novel Mutation
por: Israni, Anil V., et al.
Publicado: (2018)

Juvenile Myoclonic Epilepsy: Myoclonic Status Epilepticus without Coma - Report of Three Cases
por: Murthy, Jagarlapudi M. K.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s45jtlohpg65ctjb993ohmfhil